Iovance Biotherapeutics reported early pilot trial results for lifileucel in aggressive soft tissue sarcomas. The company plans to start a registrational trial and seek expedited FDA approval based on ...
MedPage Today on MSN
CDC Study Warns on Infection-Related Cancers After Organ Transplant
Kaposi sarcoma-associated herpesvirus testing is not routinely performed on donors or reci ...
Synovial sarcoma is an aggressive malignant tumor that primarily affects the limbs of teenagers and young adults. While it can be cured if completely removed by surgery, recurrence or metastasis, the ...
Synovial sarcoma, a rare cancer, thrives on glutamine. Blocking its nutrient supply with the drug V9302 stops tumor growth, offering a new way to treat the disease.
Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik® (tazemetostat) in all ...
Synovial sarcoma is an aggressive malignant tumor that primarily affects the limbs of teenagers and young adults.
A diagnosis of Kaposi sarcoma is a significant life event, but it is a manageable condition. Because KS is so closely linked to immune function, your treatment will likely involve a collaborative ...
Purpose Sarcomas are cancers of connective tissue and account for approximately 10–15% of all cancer cases in children aged ≤16 years. Treatment often involves chemotherapy, surgery and radiotherapy.
Results presented here showed negative pressure wound therapy is a safe adjunct for soft tissue sarcoma treated with ...
Iovance Biotherapeutics Inc. IOVA stock is trading higher on Friday, with no news to justify the movement. Investors should ...
Gor Hakobyan, an Armenian singer-actor, made a plea video seeking financial assistance for the medical treatment of his son, who is battling Ewing’s sarcoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results